PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the publication of the results ...

Phase 2a Clinical Trial Design The Phase 2a clinical trial will evaluate the ... About Dermata Therapeutics Dermata Therapeutics is a late-stage biotechnology company focusing on the treatment of ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 22, 2025 /PRNewswire/ -- USA News Group News Commentary? Big developments are expected this week at the 2025 ASCO Gastrointestinal ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

ENGWE is thrilled to announce the launch of the Mapfour N1 e-bike, the first product in its new Mapfour series. Designed to ...

You hear plenty about the cashmere caps, slip-on sneakers and limited-edition dive watches beloved by deep-pocketed men.

Logo spiral beauty twist ribbon icon vector, twirl spin rotation dna shaped logotype purple blue violet graphic, helix flow modern design symbol clipart isolated element Green plant sprout in tube.

More broadly educational cell and gene therapy topics (e.g., quality, regulatory, facility design, GXP manufacturing ... symposium advertising and BPD registration webpage. -Company logo and brief ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...